The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1
Open accessAbstract
Ferroptosis is a form of regulated cell death, characterized by excessive membrane lipid peroxidation in an iron- and ROS-dependent manner. Celastrol, a natural bioactive triterpenoid extracted from Tripterygium wilfordii, shows effective anti-fibrotic and anti-inflammatory activities in multiple hepatic diseases. However, the exact molecular mechanisms of action and the direct protein targets of celastrol in the treatment of liver fibrosis remain largely elusive. Here, we discover that celastrol exerts anti-fibrotic effects via promoting the production of reactive oxygen species (ROS) and inducing ferroptosis in activated hepatic stellate cells (HSCs). By using activity-based protein profiling (ABPP) in combination with bio-orthogonal click chemistry reaction and cellular thermal shift assay (CETSA), we show that celastrol directly binds to peroxiredoxins (PRDXs), including PRDX1, PRDX2, PRDX4 and PRDX6, through the active cysteine sites, and inhibits their anti-oxidant activities. Celastrol also targets to heme oxygenase 1 (HO-1) and upregulates its expression in activated-HSCs. Knockdown of PRDX1, PRDX2, PRDX4, PRDX6 or HO-1 in HSCs, to varying extent, elevated cellular ROS levels and induced ferroptosis. Taken together, our findings reveal the direct protein targets and molecular mechanisms via which celastrol ameliorates hepatic fibrosis, thus supporting the further development of celastrol as a promising therapeutic agent for liver fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trott, O., & Olson, A. J. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21334 · Cited by 38,412
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Yu, G., Wang, L.-G., Han, Y., & He, Q.-Y. (2012) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2011.0118 · Cited by 36,259
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Stockwell, B. R., Friedmann Angeli, J. P., Bayir, H., Bush, A. I., Conrad, M., Dixon, S. J., Fulda, S., Gascón, S., Hatzios, S. K., Kagan, V. E., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.021 · Cited by 7,695
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Broadening horizons: the role of ferroptosis in cancer
Chen, X., Kang, R., Kroemer, G., & Tang, D. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00462-0 · Cited by 2,897
Garcia‐Tsao, G., Abraldes, J. G., Berzigotti, A., & Bosch, J. (2017) · Hepatology · doi:10.1002/hep.28906 · Cited by 2,154
RAS–RAF–MEK-dependent oxidative cell death involving voltage-dependent anion channels
Yagoda, N., von Rechenberg, M., Zaganjor, E., Bauer, A. J., Yang, W. S., Fridman, D. J., Wolpaw, A. J., Smukste, I., Peltier, J. M., Boniface, J. J., et al. (2007) · Nature · doi:10.1038/nature05859 · Cited by 1,631
The cellular thermal shift assay for evaluating drug target interactions in cells
Jafari, R., Almqvist, H., Axelsson, H., Ignatushchenko, M., Lundbäck, T., Nordlund, P., & Molina, D. M. (2014) · Nature Protocols · doi:10.1038/nprot.2014.138 · Cited by 1,474
Rhee, S. G., Chae, H. Z., & Kim, K. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.02.026 · Cited by 1,409
Peroxiredoxin Evolution and the Regulation of Hydrogen Peroxide Signaling
Wood, Z. A., Poole, L. B., & Karplus, P. A. (2003) · Science · doi:10.1126/science.1080405 · Cited by 1,367
Mechanisms of Cell Protection by Heme Oxygenase-1
Gozzelino, R., Jeney, V., & Soares, M. P. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105600 · Cited by 1,241
Treatment of Obesity with Celastrol
Liu, J., Lee, J., Salazar Hernandez, M. A., Mazitschek, R., & Ozcan, U. (2015) · Cell · doi:10.1016/j.cell.2015.05.011 · Cited by 726
Metallothionein‐1G facilitates sorafenib resistance through inhibition of ferroptosis
Sun, X., Niu, X., Chen, R., He, W., Chen, D., Kang, R., & Tang, D. (2016) · Hepatology · doi:10.1002/hep.28574 · Cited by 703
Molecular Understanding and Modern Application of Traditional Medicines: Triumphs and Trials
Corson, T. W., & Crews, C. M. (2007) · Cell · doi:10.1016/j.cell.2007.08.021 · Cited by 654
Peroxiredoxin, a Novel Family of Peroxidases
Rhee, S. G., Kang, S. W., Chang, T., Jeong, W., & Kim, K. (2001) · IUBMB Life · doi:10.1080/15216540252774748 · Cited by 639
Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum
Wang, J., Zhang, C.-J., Chia, W. N., Loh, C. C. Y., Li, Z., Lee, Y. M., He, Y., Yuan, L.-X., Lim, T. K., Liu, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms10111 · Cited by 633
Self-citationYang, H., Antoine, D. J., Andersson, U., & Tracey, K. J. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1212662 · Cited by 542
Tsurusaki, S., Tsuchiya, Y., Koumura, T., Nakasone, M., Sakamoto, T., Matsuoka, M., Imai, H., Yuet-Yin Kok, C., Okochi, H., Nakano, H., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1678-y · Cited by 529
Mechanisms of Disease: mechanisms of hepatic fibrosis and therapeutic implications
Friedman, S. L. (2004) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0055 · Cited by 498
Nedd4 ubiquitylates VDAC2/3 to suppress erastin-induced ferroptosis in melanoma
Yang, Y., Luo, M., Zhang, K., Zhang, J., Gao, T., Connell, D. O., Yao, F., Mu, C., Cai, B., Shang, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14324-x · Cited by 480
Self-citationZhang, Z., Yao, Z., Wang, L., Ding, H., Shao, J., Chen, A., Zhang, F., & Zheng, S. (2018) · Autophagy · doi:10.1080/15548627.2018.1503146 · Cited by 474
A Dual Role of Heme Oxygenase-1 in Cancer Cells
Chiang, S.-K., Chen, S.-E., & Chang, L.-C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010039 · Cited by 465
Zhang, Z., Guo, M., Li, Y., Shen, M., Kong, D., Shao, J., Ding, H., Tan, S., Chen, A., Zhang, F., et al. (2020) · Autophagy · doi:10.1080/15548627.2019.1687985 · Cited by 462
The Power of Plasticity—Metabolic Regulation of Hepatic Stellate Cells
Trivedi, P., Wang, S., & Friedman, S. L. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.026 · Cited by 427
CCR2 promotes hepatic fibrosis in mice #
Seki, E., de Minicis, S., Inokuchi, S., Taura, K., Miyai, K., van Rooijen, N., Schwabe, R. F., & Brenner, D. A. (2009) · Hepatology · doi:10.1002/hep.22952 · Cited by 416
Clinical evidence for the regression of liver fibrosis
Ellis, E. L., & Mann, D. A. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.09.024 · Cited by 411
Artesunate alleviates liver fibrosis by regulating ferroptosis signaling pathway
Kong, Z., Liu, R., & Cheng, Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.030 · Cited by 360
The Global Impact of Hepatic Fibrosis and End-Stage Liver Disease
Lim, Y.-S., & Kim, W. R. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.007 · Cited by 316
Tomita, K., Teratani, T., Suzuki, T., Shimizu, M., Sato, H., Narimatsu, K., Okada, Y., Kurihara, C., Irie, R., Yokoyama, H., et al. (2014) · Hepatology · doi:10.1002/hep.26604 · Cited by 315
Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma
Li, Z.-J., Dai, H.-Q., Huang, X.-W., Feng, J., Deng, J.-H., Wang, Z.-X., Yang, X.-M., Liu, Y.-J., Wu, Y., Chen, P.-H., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0478-3 · Cited by 315
Self-citationChen, X., Zhao, Y., Luo, W., Chen, S., Lin, F., Zhang, X., Fan, S., Shen, X., Wang, Y., & Liang, G. (2020) · Theranostics · doi:10.7150/thno.46728 · Cited by 291
Ferroptosis and Its Potential Role in Human Diseases
Han, C., Liu, Y., Dai, R., Ismail, N., Su, W., & Li, B. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00239 · Cited by 273
Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells
Liu, C.-X., Yin, Q.-Q., Zhou, H.-C., Wu, Y.-L., Pu, J.-X., Xia, L., Liu, W., Huang, X., Jiang, T., Wu, M.-X., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.935 · Cited by 221
The BRD7-P53-SLC25A28 axis regulates ferroptosis in hepatic stellate cells
Zhang, Z., Guo, M., Shen, M., Kong, D., Zhang, F., Shao, J., Tan, S., Wang, S., Chen, A., Cao, P., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101619 · Cited by 189
Liver fibrosis: mechanisms of immune-mediated liver injury
Xu, R., Zhang, Z., & Wang, F.-S. (2012) · Cellular & Molecular Immunology · doi:10.1038/cmi.2011.53 · Cited by 183
HMGB1 regulates ferroptosis through Nrf2 pathway in mesangial cells in response to high glucose
Wu, Y., Zhao, Y., Yang, H.-Z., Wang, Y.-J., & Chen, Y. (2021) · Bioscience Reports · doi:10.1042/bsr20202924 · Cited by 182
Hou, W., Liu, B., & Xu, H. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112081 · Cited by 170
Modulation of Protein-Interaction States through the Cell Cycle
Dai, L., Zhao, T., Bisteau, X., Sun, W., Prabhu, N., Lim, Y. T., Sobota, R. M., Kaldis, P., & Nordlund, P. (2018) · Cell · doi:10.1016/j.cell.2018.03.065 · Cited by 168
Self-citationJia, Y., Wang, F., Guo, Q., Li, M., Wang, L., Zhang, Z., Jiang, S., Jin, H., Chen, A., Tan, S., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2018.09.007 · Cited by 162
Identification of PRDX6 as a regulator of ferroptosis
Lu, B., Chen, X., Hong, Y., Zhu, H., He, Q., Yang, B., Ying, M., & Cao, J. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0233-9 · Cited by 161
Sui, M., Jiang, X., Chen, J., Yang, H., & Zhu, Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.060 · Cited by 155
Self-citationCelastrol in metabolic diseases: Progress and application prospects
Xu, S., Feng, Y., He, W., Xu, W., Xu, W., Yang, H., & Li, X. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105572 · Cited by 129
Wang, J., Tan, X. F., Nguyễn, V. S., Yang, P., Zhou, J., Gao, M., Li, Z., Lim, T. K., He, Y., Ong, C. S., et al. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.029793 · Cited by 111
Self-citationIn situ Proteomic Profiling of Curcumin Targets in HCT116 Colon Cancer Cell Line
Wang, J., Zhang, J., Zhang, C., Wong, Y. K., Lim, T. K., Hua, Z., Liu, B., Tannenbaum, S. R., Shen, H., & Lin, Q. (2016) · Scientific Reports · doi:10.1038/srep22146 · Cited by 106
Self-citationCelastrol exerts anti‐inflammatory effect in liver fibrosis via activation of AMPK‐SIRT3 signalling
Wang, Y., Li, M., Gu, J., Chen, C., Duanmu, J., Miao, J., Yao, W., Tao, J., Tu, M., Xiong, B., et al. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14805 · Cited by 106
Isotopically-Labeled Iodoacetamide-Alkyne Probes for Quantitative Cysteine-Reactivity Profiling
Abo, M., Li, C., & Weerapana, E. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00832 · Cited by 104
Peroxiredoxin-1 regulates lipid peroxidation in corneal endothelial cells
Lovatt, M., Adnan, K., Kocaba, V., Dirisamer, M., Peh, G. S. L., & Mehta, J. S. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101417 · Cited by 104
Kuo, C., Chiu, V. J.-Y., Hsieh, P., Chun-Yen, H., Huang, S.-T. J., Tzeng, I., Tsai, F., Chen, M., Liu, C.-T., & Chen, Y.-R. (2020) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2020.07.014 · Cited by 104
Zhang, Z., Yao, Z., Zhao, S., Shao, J., Chen, A., Zhang, F., & Zheng, S. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.255 · Cited by 97
Li, Y., Jin, C., Shen, M., Wang, Z., Tan, S., Chen, A., Wang, S., Shao, J., Zhang, F., Zhang, Z., et al. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.09.008 · Cited by 90
Yan, C., Ouyang, S., Wang, X., Wu, Y., Sun, W., Duan, W., Liang, L., Luo, X., Kurihara, H., Li, Y.-F., et al. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153398 · Cited by 87
Liu, D., Luo, P., Gu, L., Zhang, Q., Gao, P., Zhu, Y., Chen, X., Guo, Q., Zhang, J., Ma, N., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02216-w · Cited by 87
Self-citationArtesunate-induced mitophagy alters cellular redox status
Zhang, J., Sun, X., Wang, L., Wong, Y. K., Lee, Y. M., Zhou, C., Wu, G., Zhao, T., Liu, Y., Lu, L., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2018.07.025 · Cited by 86
Self-citationCelastrol Protects From Cholestatic Liver Injury Through Modulation of SIRT1-FXR Signaling
Zhao, Q., Liu, F., Cheng, Y., Xiao, X.-R., Hu, D., Tang, Y., Bao, W.-M., Yang, J., Jiang, T., Hu, J., et al. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.000817 · Cited by 69
Pradhan‐Sundd, T., Zhou, L., Vats, R., Jiang, A., Molina, L. M., Singh, S., Poddar, M., Russell, J. O., Stolz, D. B., Oertel, M., et al. (2017) · Hepatology · doi:10.1002/hep.29585 · Cited by 61
Chang, W., He, W., Li, P., Song, S., Yuan, P., Lu, J., & Wei, W. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.04.045 · Cited by 58
Zhao, Q. C., Ding, Y., Deng, Z., Lee, O., Gao, P., Chen, P., Rose, R., Zhao, H., Zhang, Z., Tao, X.-P., et al. (2015) · Chemical Science · doi:10.1039/c5sc00633c · Cited by 55
Celastrol ameliorates acute liver injury through modulation of PPARα
Zhao, Q., Tang, P., Zhang, T., Huang, J., Xiao, X.-R., Zhu, W., Gonzalez, F. J., & Li, F. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114058 · Cited by 40
Bian, M., Chen, X., Zhang, C., Jin, H., Wang, F., Shao, J., Chen, A., Zhang, F., & Zheng, S. (2017) · BioFactors · doi:10.1002/biof.1390 · Cited by 36
Cited by
Zhu, Y., Ouyang, Z., Du, H., Wang, M., Wang, J., Sun, H., Kong, L., Xu, Q., Ma, H., & Sun, Y. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.08.022 · Cited by 414
Self-citationRedox regulation: mechanisms, biology and therapeutic targets in diseases
Li, B., Ming, H., Qin, S., Nice, E. C., Dong, J., Du, Z., & Huang, C. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02095-6 · Cited by 317
ROS/RNS as molecular signatures of chronic liver diseases
Che, Z., Zhou, Z., Li, S.-Q., Gao, L., Xiao, J., & Wong, N.-K. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.08.001 · Cited by 110
Wang, Z., Yuan, M., Yao, L., Xiong, Z., Dai, K., Liu, P., Chen, P., Sun, M., Shu, K., Xia, Y., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03291-4 · Cited by 27
Metadata
- Authors
- Luo, P., Liu, D., Zhang, Q., Yang, F., Wong, Y.-K., Xia, F., Zhang, J., Chen, J., Tian, Y., Yang, C., Dai, L., Shen, H.-M., & Wang, J.
- Venue
- Acta Pharmaceutica Sinica B
- Publisher
- Elsevier BV
- Published
- 2022-05
- Volume
- 12
- Issue
- 5
- Pages
- 2300-2314
- ISSN
- 2211-3835 (ISSN-L)
- OpenAlex
- W4200516838
- Cited by
- 377
- References
- 60
- FWCI
- 20.27
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.